Join
Live feed
·
PRReleasevia Quantisnow
MyMD Pharmaceuticals Inc. logo
PharmaCyte Biotech Inc. logo

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

ByQuantisnow·Wall Street's wire, on your screen.
MYMD· MyMD Pharmaceuticals Inc.PMCB· PharmaCyte Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYMD (MyMD Pharmaceuticals Inc.), PMCB (PharmaCyte Biotech Inc.) and more on Quantisnow.